Jiajia Chen
Shenyang, 110004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
STING signaling pathway: An oasis in the glioblastoma immune desert.
Journal: Theranostics
Published: November 10, 2025
Aberrant ATM signaling and homology-directed DNA repair as a vulnerability of p53-mutant GBM to AZD1390-mediated radiosensitization.
Journal: Science translational medicine
Published: February 14, 2024
Radiotherapy-resistant prostate cancer cells escape immune checkpoint blockade through the senescence-related ataxia telangiectasia and Rad3-related protein.
Journal: Cancer communications (London, England)
Published: February 11, 2024
Effectiveness of Enhanced Recovery After Surgery-Based Respiratory Function Exercise in Elderly Patients with Lung Cancer and its Effect on Postoperative Functional Recovery.
Journal: Alternative therapies in health and medicine
Published: July 13, 2023
BRD4: New hope in the battle against glioblastoma.
Journal: Pharmacological research
Published: February 02, 2023
ATM inhibition exploits checkpoint defects and ATM-dependent double strand break repair in TP53-mutant glioblastoma.
Journal: Nature communications
Published: December 20, 2022
Correction: Knockdown of SOX2OT inhibits the malignant biological behaviors of glioblastoma stem cells via up-regulating the expression of miR-194-5p and miR-122.
Journal: Molecular cancer
Published: October 23, 2022
Central Nervous System Distribution of the Ataxia-Telangiectasia Mutated Kinase Inhibitor AZD1390: Implications for the Treatment of Brain Tumors.
Journal: The Journal of pharmacology and experimental therapeutics
Published: March 24, 2022
Corrigendum: Decreased DUSP26 Expression Promotes Malignant Behavior in Glioblastoma Cells via Deregulation of MAPK and Akt Signaling Pathway.
Journal: Frontiers in oncology
Published: March 05, 2021
Last Updated: 09/26/2026